All blog posts
Total 255 results for
Showing 12 out of 255 results
30 7月 2026
The UPC at Three Years
15 5月 2026
Mediation and expert determination at PMAC - the UPC's Patent Mediation and Arbitration Centre
15 5月 2026
The Arbitration Rules of the Unified Patent Court's Patent Mediation and Arbitration Centre
13 5月 2026
The UPC's Patent Mediation and Arbitration Centre (PMAC) to commence operation on 2 June 2026: A turning point for patent dispute resolution?
27 4月 2026
The EU Pharma Package is finally here – here's the settled position on key areas
01 4月 2026
IP Australia releases consultation paper on IP reforms
12 3月 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
19 1月 2026
Where is the UPC after two and a half years - and what to expect in 2026?
23 12月 2025
Mixing it up: The end of the line for patent term extensions for formulation patents in Australia
15 12月 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
09 12月 2025
Preserving the status quo: Boehringer Ingelheim awarded interim injunction
02 12月 2025
UPC holds CE marking approval is evidence of imminent infringement and starts the clock running where considering any (unreasonable) delay in a PI application
Showing 12 out of 255 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
雷鹏
科伟史密夫斐尔凯迈联营办公室合伙人, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London